Abstract:
The present application is directed to the use of a VEGF-C inhibitor, a VEGFR-2 inhibitor and/or a VEGFR-3 inhibitor as a prophylactic or therapeutic for the treatment of eye disorders such as a maculopathy and pathogenic ocular neovascularisation. The application is also directed to the use of a VEGF-C measurement from a biological sample from a mammalian subject as a predictive marker, a selected marker, a responsive marker or a tracking marker for a disease or condition selected from the group consisting of a maculopathy and pathogenic ocular neovascularization.
Abstract:
A computer-implemented method may be provided. The method may be performed by a server system having one or more servers and memory storing one or more programs for execution by the one or more servers. The method may comprise, at the server system: receiving an access request to a network server from a terminal device; determining whether the access request matches a cached record stored in an substitute server; if the cached record is found, returning the cached record to the terminal device; if no cached record is found, processing the access request for security check; forwarding the processed access request to the network server; receiving a response from the network server; optimizing the response from the network server; and forwarding the optimized response to the terminal device.